(m, 2 H), 1.55 (m, 1 H), 1.43 and 1.39 (2 s, each 3 H, CMe2)
and 1.35 (m, 1 H); δC(CDCl3) 143.57, 134.61, 129.73, 127.59,
109.40, 77.41, 67.56, 62.05, 49.17, 29.95, 26.52, 25.15, 24.06
and 21.52.
ml) was hydrogenated (1 atm) in the presence of palladized
charcoal (10%; 60 mg) for 6 h and was then processed as
described above. Distillation in vacuo (Kügelrohr, 80 ЊC/0.5
mbar) of the material gave pure compound 22 (0.322 g,
62.5%), [α]D ϩ16 (Found: C, 63.4; H, 9.86; N, 8.01. C9H17NO2
requires C, 63.12; H, 10.01; N, 8.18%); δH(CDCl3) 4.04 (m,
2 H, H2-5Ј), 3.76 (dd, J 8 and 6, 1 H, H-4Ј), 3.15 (m, 1 H,
H-2), 2.92 (m, 2 H, H2-5), 1.96 (br s, 1 H, NH), 1.95–1.54
(m, 4 H, H2-3 and -4) and 1.42 and 1.35 (2 s, each 3 H,
CMe2); δC(CDCl3) 108.97, 78.86, 67.59, 60.53, 46.98, 28.19,
26.65, 25.71 and 25.26; m/z 172 (Mϩ ϩ 1, 3.25%), 156 (4.08),
96 (15.37), 70 (100) and 43 (32.51); νmax(neat)/cmϪ1 3340, 2920
and 1690.
Treatment of a portion (100 mg) of compound 22 in the
manner described above for compound 14 gave the N-toluene-
p-sulfonate 23 (109 mg, 57%), mp 71.5–72.5 ЊC (from light pet-
roleum); [α]D ϩ95.3 (Found: C, 59.23; H, 7.04; N, 4.33; S, 9.90.
C16H23NO4NS requires C, 59.05; H, 7.12; N, 4.30; S, 9.85%);
δH(CDCl3) 7.73 and 7.32 (2 d, J 8.5 and 6.3, each 1 H, ArH),
4.54 (dt, J 6.6 and 4.0, 1 H, H-4Ј), 4.10 (dd, J 9 and 6.8, 1 H, Ha-
5Ј), 3.98 (dd, J 9 and 6.4, 1 H, Hb-5Ј), 3.82 (quintet, J 4.2, H-2),
3.35 (m, 2 H, H2-5), 2.43 (s, 3 H, C6H4Me), 1.89–1.60 (m, 3 H),
1.42 and 1.35 (2 s, each 3 H, CMe2) and 1.33 (m, 1 H);
δC(CDCl3) 143.66, 134.10, 129.71, 127.70, 109.26, 77.51, 65.61,
50.24, 27.29, 26.17, 24.99, 24.44 and 21.53.
(2R,4ЈS)-N-Benzyloxycarbonyl-2-(2Ј,2Ј-dimethyl-1Ј,3Ј-
dioxolan-4Ј-yl)pyrrolidine 16
Treatment of a stirred solution of free amine 14 (336 mg, 1.97
mmol) in 50% aq. ethanol (25 ml), containing sodium hydrogen
carbonate (336 mg), with benzyl chloroformate (0.45 ml, 3.2
mmol) followed by processing in the usual manner and column
chromatography (hexane–ethyl acetate, 3:1) of the resulting
material gave compound 16 (491 mg, 82%), [α]D ϩ59;
δH(CDCl3) 7.33 (m, 5 H, Ph), 5.13 (qAB, J 15.6 and 12.4, 2 H,
PhCH2), 4.41 (m, 1 H), 4.13 (m, 1 H), 3.9 (m, 1 H), 3.84 (m, 1
H), 3.61 (m, 1 H), 3.36 (m, 1 H), 2.00–1.78 (m, 4 H, H2-3 and
-4) and 1.37 and 1.33 (2 s, each 3 H, CMe2); δC(CDCl3) 155.52,
136.64, 128.33, 127.83, 127.74, 108.77, 77.48, 66.80, 65.81,
57.75, 47.39, 27.66, 26.08, 25.19 and 23.89; m/z 290 (Mϩ Ϫ 15,
1.95%), 160 (40.21), 91 (100) and 43 (18.21); νmax(film)/cmϪ1
3030, 2960, 2880, 1820 and 1680.
Methyl 4-azido-2,3,4-trideoxy-5,6-O-isopropylidene-D-erythro-
hexonate [(4S,5S)-methyl 4-azido-5,6-(isopropylidenedioxy)-
hexanoate] 19
A stirred solution of compound 183 (2.85 g, 10.2 mmol) in dry
DMF (24 ml) was treated with lithium azide33 (2.45 g, 50 mmol)
and then was set aside at room temp. for 7 days. The mixture
was treated with a mixture of diethyl ether (100 ml) and water
(100 ml). The separated aqueous layer was extracted with a
further portion of diethyl ether (100 ml) and the combined
ether layers were washed successively with saturated aq. sodium
chloride and water, dried (Na2SO4), and concentrated in vacuo.
Flash column chromatography (hexane–ethyl acetate, 3:1) of
the resultant residue gave pure (GLC) compound 19 (1.58 g,
65%) as an oil, [α]D Ϫ45; δH(CDCl3) 4.07 (m, 2 H, H-5, Ha-6),
3.89 (dd, J 8 and 6, 1 H, Hb-6), 3.70 (s, 3 H, OCH3), 3.59 (m, 1
H, H-4), 2.50 (m, 2 H, H2-2), 1.96 (m, 1 H, Ha-3), 1.60 (m, 1 H,
Hb-3) and 1.47 and 1.36 (2 s, each 3 H, CMe2); δC(CDCl3)
173.06, 109.79, 77.73, 65.80, 62.72, 51.74, 30.44, 26.17, 26.05
and 25.09; m/z 228 (Mϩ Ϫ 15, 10%), 216 (3.7), 130 (3.2), 101
(57), 98 (22), 83 (16.5), 59 (20) and 43 (100); νmax(film)/cmϪ1
2980, 2110, 1730, 1240 and 1060.
(2S,4ЈS)-N-Benzyloxycarbonyl-2-(2Ј,2Ј-dimethyl-1Ј,3Ј-dioxolan-
4Ј-yl)pyrrolidine 24
Treatment of a portion of compound 22 (260 mg, 1.52 mmol)
with benzyl chloroformate (0.23 ml, 1.52 mmol) followed by
processing in the usual manner, and column chromatography
(hexane–ethyl acetate, 3:1), gave compound 24 (302 mg,
65%), [α]D Ϫ39; δH(400 MHz; 61 ЊC; CDCl3) 7.52 (m, 5 H,
Ph), 5.13 (qAB, J 19.6 and 12.5, 2 H, PhCH2), 4.26 (m, 1 H),
3.99 (m, 1 H), 3.76 (m, 1 H), 3.49 (m, 2 H), 2.02 (m, 2 H),
1.85 (m, 2 H) and 1.40 and 1.31 (2 s, each 3 H, CMe2);
δC(61 ЊC; CDCl3) 155.29, 137.00, 128.50 and 127.91 (2×),
127.56, 109.10, 76.67, 67.69, 66.86, 55.54, 47.06, 26.36 (2×),
25.20 and 23.82; m/z 306 (Mϩ ϩ 1, 0.18%), 290 (1.5), 160
(35.34), 91 (100) and 43 (16.49); νmax(film)/cmϪ1 3430, 3020,
2960, 2800 and 1690.
(2R,1ЈS)-N-Benzyloxycarbonyl-2-(1,2-dihydroxyethyl)pyrroli-
dine 17
(5S,4ЈS)-5-(2Ј,2Ј-Dimethyl-1Ј,3Ј-dioxolan-4Ј-yl)pyrrolidin-2-one
20
A solution of compound 16 (491 mg) in 80% aq. acetic acid (10
ml) was set aside at room temperature for 5 days and was then
concentrated in vacuo. Water (5 ml), followed by toluene (3 × 10
ml) was distilled in vacuo from the residue to give diol 17 (403
mg, 95%) as an oil, [α]D ϩ66; δH(CDCl3) 7.36 (m, 5 H, Ph), 5.15
(s, 2 H, PhCH2), 4.05 (m, 1 H, H-2), 3.60 (m, 1 H), 3.37 (m, 1 H)
and 2.09–1.73 (m, 4 H, H2-3 and -4); δC 157.90, 136.15, 128.14,
128.14, 128.03, 127.80, 75.64, 67.45, 64.04, 59.99, 47.31, 28.48
and 24.12; m/z 266 (Mϩ ϩ 1, 0.16%), 204 (40.24), 160 (45.83),
114 (7.79), 91 (100), 70 (17.04), 65 (14.85), 43 (10.32), 41
(15.28), 39 (13.27), 31 (8.33) and 28 (19.73); νmax(KBr)/cmϪ1
3400, 3030, 2940, 2885 and 1665.
Reductive cyclization of compound 19 (0.458 g, 1.89 mmol) in
the manner described above for compound 11 gave the lactam
20 (0.206 g, 59%), mp 125–126 ЊC (from diisopropyl ether–
dichloromethane); [α]D ϩ28.2 (Found: C, 58.40; H, 7.91; N,
7.53. C9H15NO3 requires C, 58.36; H, 8.16; N, 7.56%); δH(100
MHz; CDCl3) 6.60 (br s, 1 H, NH), 4.06–3.77 (m, 4 H, H-4Ј, -5
and H2-5Ј), 2.45–1.75 (m, 4 H, H2-3 and -4) and 1.43 and 1.35
(2 s, each 3 H, CMe2); νmax(film)/cmϪ1 3430, 1690 and 1650.
(4S,5S)-4-Azido-5,6-(isopropylidenedioxy)hexanal 21
A solution of compound 19 (1.26 g, 5.19 mmol) was treated
with DIBAL (6.23 ml) and processed as described above. Col-
umn chromatography (light petroleum–ethyl acetate, 3:1) of
the resulting material gave the aldehyde 21 (0.85 g, 77%), [α]D
ϩ46, as an oil; δH(CDCl3) 9.81 (s, 1 H, CHO), 4.08 (m, 2 H, H-
5, Ha-6), 3.91 (dd, 1 H, J 8 and 5, Hb-6), 3.55 (quintet, J 5, 1 H,
H-4), 2.65 (m, 2 H, H2-2), 1.97 (m, 1 H, Ha-3), 1.60 (m, 1 H, Hb-
3) and 1.47 and 1.36 (2 s, each 3 H, CMe2); δC(CDCl3) 200.76,
109.85, 77.69, 65.86, 62.70, 40.29, 26.19, 25.07 and 23.24; m/z
186 (Mϩ ϩ 1 Ϫ 28, 0.45%), 101 (44.49), 82 (16.35), 55 (11.06)
and 43 (100); νmax/cmϪ1 2980, 2890, 2720, 2120 and 1700.
(2S,1ЈS)-N-Benzyloxycarbonyl-2-(1,2-dihydroxyethyl)pyrroli-
dine 25
Treatment of compound 24 (302 mg) with 80% aq. acetic acid
(15 ml), followed by processing in the above manner, yielded
compound 25 (235 mg, 90%), [α]D Ϫ20; δH(CDCl3) 7.35 (m, 5
H, Ph), 5.14 (qAB, J 12.7 and 12.7, 2 H), 3.92 (1 H, m, H-2),
3.59 (br s, 1 H, H-4Ј), 3.46 (m, 3 H), 2.09 (m, 1 H) and 1.91
(m, 3 H); δC(CDCl3) 158.8, 136.3, 128.51, 128.1, 127.81, 72.62,
67.41, 62.73, 59.32, 47.18, 27.62 and 23.31; m/z 266 (Mϩ ϩ 1,
0.16%), 204 (40.24), 160 (45.83), 114 (4.34), 91 (100), 70
(13.74), 65 (27.77), 43 (28.04), 41 (21.55), 39 (18.89), 31
(19.97) and 28 (13.94); νmax(KBr)/cmϪ1 3380, 3020, 2950, 2880
and 1660.
(2S,4ЈS)-2-(2Ј,2Ј-Dimethyl-1Ј,3Ј-dioxolan-4Ј-yl)pyrrolidine 22
A solution of compound 21 (0.64 g, 3.0 mmol) in methanol (20
3354
J. Chem. Soc., Perkin Trans. 1, 1997